Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Blocking Prostaglandin D₂ may help treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Viprostol does not effectively promote hair growth in male pattern baldness.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Finasteride slows down motherly behavior in first-time pregnant rats.

Blocking a protein called prostaglandin D2 might help treat hair loss.

A new method effectively detects trace sex hormones in cosmetics, ensuring safety.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

The inhibitor DPP can promote hair growth.

GD-23 reduces anxiety by relying on neurosteroid production.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.